PaulEKeckJr.MD

PubMed

• 1010 citations
  Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.
  Robert M. A. Hirschfeld, Janet B.W. Williams, Robert L. Spitzer, Joseph R. Calabrese, Laurie M. Flynn
  The American Journal of Psychiatry. 2000-11-01
• 422 citations
  Are Mood Disorders and Obesity Related? A Review for the Mental Health Professional
  Susan L. McElroy, Renu Kotwal, Shishuka Malhotra, Erik Nelson, Paul E. Keck
  The Journal of Clinical Psychiatry. 2004-05-01
• 299 citations
  Compulsive buying : a report of 20 cases
  Susan L. McElroy, Paul E. Keck, Harrison G. Pope, Jacqueline M. R. Smith, Stephen M. Strakowski
  The Journal of Clinical Psychiatry. 1994-01-01

Journal Articles

• Prevalence of Axis II comorbidities in bipolar disorder: relationship to mood state  
  Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Nolen W, Leverich GS, Bipolar Disorders, 1/1/2018
• Would glucagon peptide-1 receptor agonists have efficacy in binge eating disorder and bulimia nervosa?  
  McElroy SL, Mori N, Guerdjikova A, Keck PE, Jr., Medical Hypotheses, 1/1/2018
• Axis II personality disorders are linked to an adverse course of bipolar disorder  
  Post RM, McElroy S, Kupka R, Suppes T, Hellemann G, Nolen W, Frye M, Keck P, Grunze H, Rowe M, Journal of Nervous and Mental Disease, 1/1/2018
• Illnesses in siblings of US patients with bipolar disorder relate to multigenerational family history and patients' severity of illness  
  Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Jr, Nolen WA, Journal of Affective Disorders, 1/1/2017
• More childhood onset bipolar disorder in the United States than Canada or Europe: Implications for treatment and prevention  
  Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Jr, Leverich GS, Nolen WA, Neuroscience and Biobehavioral Reviews, 1/1/2017
• Switch rates during lithium monotherapy, sertraline monotherapy, and lithium/sertraline combination therapy for the acute treatment of bipolar II depression: a randomi...  
  Altshuler LL, Sugar CA, McElroy SL, Calimlim B, Gitlin M, Keck PE, Jr, Aquino-Elias A, Martens BE, Fisher EG, English TA, Suppes T, American Journal of Psychiatry, 1/1/2017
• Guidelines for the recognition and management of mixed depression  
  Stahl S, Morrissette DA, Faedda G, Fava M, Goldberg JF, Keck PE, Lee Y, Malhi G, Marangoni C, McElroy SL, Ostacher M, Rosenblat JD, Sole E, Suppes T, Takeshima M, Thas..., CNS Spectrums, 1/1/2017
• The relationship between self-reported borderline personality features and prospective course in bipolar disorder  
  Reimann G, Weisscher N, Post RM, Altshuler LL, McElroy SL, Frye MA, Keck PE, Jr, Leverich GS, Suppes T, Grunze H, Nolen We, Kupka RW, International Journal of Bipolar Disorders, 1/1/2017
• More illness in offspring of bipolar patients from the US compared to Europe  
  Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Jr, Leverich GS, Nolen WA, Journal of Affective Disorders, 1/1/2016
• Clinical correlates of sustained response to individual drugs used in naturalistic treatment of patients with bipolar disorder  
  Post RM, Kupka RW, Nolen WA, Altshuler LA, Suppes T, Frye MA, McElroy SL, Keck PE, Jr, Leverich GS, Grunze H, Rowe M, Comprehensive Psychiatry, 1/1/2016
• Mixed depression in bipolar disorder: prevalence rate and clinical correlates during naturalistic follow-up in the Stanley Bipolar Network  
  Miller S, Suppes T, Mintz J, Hellemann G, Frye MA, McElroy SL, Nolen WA, Kupka R, Leverich GS, Grunze H, Altshuler LL, Keck PE, Jr, Post RM, American Journal of Psychiatry, 1/1/2016
• Further evidence of a cohort effect in bipolar disorder: more early onsets and family history of psychiatric illness in more recent epochs  
  Post RM, Kupka R, Keck PE, Jr, McElroy SL, Altshuler LL, Frye MA, Rowe M, Grunze H, Suppes T, Leverich GS, Nolen WA, Journal of Clinical Psychiatry, 1/1/2016
• Managing comorbid obesity and depression through clinical pharmacotherapies  
  McElroy SL, Guerdjikova AI, Mori N, Keck PE, Jr., Expert Opinion in Pharmacotherapy, 1/1/2016
• Mixed depression in bipolar disorder: prevalence rate and clinical correlates during naturalistic follow-up  
  Miller S, Suppes T, Mintz J, Helleman G, Frye M, McElroy SL, Nolen W, Kupka R, Leverich G, Grunze H, Altshuler LL, Keck PE, Jr, Post RM, American Journal of Psychiatry, 1/1/2016
• Age of onset of bipolar disorder: Combined effect of childhood adversity and familial loading of psychiatric disorders  
  Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Jr, Leverich GS, Nolen WA, Journal of Psychiatric Research, 1/1/2016
• Lisdexamfetamine dimesylate in binge eating disorder: a placebo-controlled trial  
  Guerdjikova AI, Mori N, Blom TJ, Keck PE, Jr, Williams SL, Welge JA, McElroy SL, Human Psychopharmacology, 1/1/2016
• Medical comorbidity of binge eating disorder  
  Olquin P, Fuentes M, Gabler G, Guerjikova AI, Keck PE, Jr, McElroy SL, Eating and Weight Disorders, 1/1/2016
• Dysphoric mania, mixed stages, and mania with mixed features specifier: are we mixing things up?  
  McElroy SL, Keck PE, Jr., CNS Spectrums, 1/1/2016
• Age of onset of bipolar disorder related to parental and grandparental illness burden  
  Post RM, Leverich GS, Kupka R, Keck PE, Jr, McElroy SL, Altshuler LL, Frye MA, Rowe M, Grunze H, Suppes T, Nolen WA, Journal of Clinical Psychiatry, 1/1/2016
• Relationship of clinical course of illness variables to medical comorbidities in 900 adult outpatients with bipolar disorder  
  Post RM, Altshuler LL, Leverich GS, Frye MA, Suppes T, McElroy SL, Keck PE, Jr, Nolen WA, Kupka RW, Grunze H, Rowe M, Comprehensive Psychiatry, 1/1/2015
• The impact of verbal abuse on the course of bipolar disorder in patients from the United States  
  Post RM, Altshuler LL, Kupka R, McElroy SL, Frey MA, Rowe M, Leverich GS, Grunze H, Suppes T, Keck PE, Jr, Nolen WA, Bipolar Disorders, 1/1/2015
• Psychopharmacologic treatment of eating disorders: emerging findings  
  McElroy SL, Guerdjikova AI, Mori N, Keck PE, Jr., Current Psychiatry Reports, 1/1/2015
• Adjunctive lisdexamfetamine in bipolar depression: a preliminary randomized, placebo-controlled trial  
  McElroy SL, Martens BE, Mori N, Blom TJ, Casuto LS, Hawkins JM, Keck PE, Jr., International Clinical Psychopharmacology, 1/1/2015
• Efficacy and safety of low- and high-dose cariprazine in patients with acute and mixed mania associated with bipolar I disorder  
  Calabrese JR, Keck PE, Jr, Starace A, Lu K, Ruth A, Laszlovszky I, Nemeth G, Durgam S, Journal of Clinical Psychiatry, 1/1/2015
• Communication between psychiatrists and patients with suspected or diagnosed binge eating disorder  
  Kornstein SG, Keck PE, Jr, Herman BK, Puhl RM, Wilfley DE, DiMarco ID, Charap ES, Postgraduate Medicine, 1/1/2015
• Join now to see all

Books/Book Chapters

• Treatment of Bipolar Disorder: Integrative Clinical Strategies and Future Directions 
  Chapter: The impact of psychiatric comorbidity in the treatment of bipolar disorder: focus on co-occurring attention deficit hyperactivity disorder and eating disorders. 
  Page 486 - 497Guerdjikova AI, Keck PE, Jr, McElroy SLEditors: Carvalho AF, Vieta E.Oxford University Press, New York, NY2017
• Guide to Treatments that Work 
  Chapter: Treatment of bipolar disorder. 
  Page 237 - 272Keck PE, Jr, McElroy SLEditors: Gorman JM, Nathan PE.Oxford University Press, New York, NYEdition 4th,2015
• The Bipolar Book 
  Chapter: Treatment of mania and mixed states. 
  Page 263 - 280Keck PE, Jr, McElroy SL, Yildiz AEditors: Yildiz A, Nemeroff CB, Ruiz R.Oxford University Press, New York, NY2015
• Essentials of Psychopharmacology 
  Chapter: Topiramate. 
  Page 507 - 522McElroy SL, Keck PE, Jr.Editors: Schatzberg AF, Nemeroff CB.American Psychiatric Publishing, Inc., Washington, DCEdition 3rd,2013
• Essentials of Psychopharmacology 
  Chapter: Treatment of bipolar disorder. 
  Page 591 - 606Keck PE, Jr, McElroy SLEditors: Schatzberg AF, Nemeroff CB.American Psychiatric Publishing, Inc., Washington, DCEdition 3rd,2013
• Oxford Handbook of Eating Disorders 
  Chapter: Pharmacotherapy of Eating Disorders. 
  Page 417 - 451McElroy SL, Guerdjikova AI, O'Melia A, Mori N, Keck PE, Jr.Editors: Agras WS, Harmon K.Oxford University Press, London, UK2010
• Textbook of Bipolar Disorders 
  Chapter: Acute Mania. 
  Page 285 - 293Keck PE, Jr, McElroy SL, Hawkins JMEditors: Yatham LN, Maj M.John Wiley & Sons, Inc., London, UK2010
• Textbook of Psychopharmacology 
  Chapter: Topiramate. 
  Page 795 - 810McElroy SL, Keck PE, Jr.Editors: Schatzberg AF, Nemeroff CB.American Psychiatric Publishing, Inc., Washington, DCEdition 4th,2009
• Textbook of Psychopharmacology 
  Chapter: Treatment of bipolar disorder. 
  Page 1113 - 1134Keck PE, Jr, McElroy SLEditors: Schatzberg AF, Nemeroff CB.American Psychiatric Publishing, Inc., Washington, DCEdition 4th,2009
• Antiepileptic Drugs to Treat Psychiatric Disorders 
  McElroy SL, Keck PE, Jr, Post RMInforma Healthcare, New York, NY2008
• Progress in Brain Research: Serotonin-Dopamine Interaction: Experimental and Therapeutic Relevance 
  Chapter: Role of serotonin and dopamine receptor binding in antipsychotic efficacy. 
  Page 155 - 175Richtand NM, Welge JA, Logue AD, Keck PE, Jr, Strakowski SM, McNamara RKEditors: DiGiovanni G, DiMatteo V, Esposito E.Elsevier BV Press, Amsterdam2008
• Antiepileptic Drugs to Treat Psychiatric Disorders 
  Chapter: Treatment of acute manic and mixed episodes. 
  Page 129 - 138Keck PE, Jr, McElroy SL, Strawn JREditors: McElroy SL, Keck PE, Jr, Post RM.Informa Healthcare, New York, NY2008
• Antiepileptic Drugs to Treat Psychiatric Disorders 
  Chapter: Antiepileptic drugs in obesity, psychotropic-associated weight gain, and eating disorders. 
  Page 283 - 310McElroy SL, Guerdjikova A, Keck PE, Jr, Pope HG, Jr, Hudson JIEditors: McElroy SL, Keck PE, Jr, Post RM.Informa Healthcare, New York, NY2008
• Decoding Bipolar Disorder: Practical Treatment and Management 
  Suppes T, Manning JS, Keck PE, Jr.Compact Clinicals Medical Publishers, Kansas City, MO2007
• Gabbard's Treatments of Psychiatric Disorders 
  Chapter: Impulse-control disorders. 
  Page 877 - 888McElroy SL, Keck PE, Jr.American Psychiatric Press, Inc., Washington, DCEdition 4th,2007
• Managing Metabolica Abnormalities in the Psychiatrically Ill. A Clinical Guide for Psychiatrists. 
  Chapter: Metabolic risk assessment, monitoring, and interventions: translating what we have learned into practice. 
  Page 277 - 302Bermudes RA, Keck PE, Jr, McElroy SLEditors: Bermudes RA, Keck PE, Jr, McElroy SL.American Psychiatric Publishing, Inc., Washington, DC2007
• Managing Metabolica Abnormalities in the Psychiatrically Ill. A Clinical Guide for Psychiatrists. 
  Chapter: Severe mental illness and diabetes mellitus. 
  Page 121 - 138Keck PE, Jr, McElroy SL, Kaneria REditors: Bermudes RA, Keck PE, Jr, McElroy SL.American Psychiatric Publishing, Inc., Washington, DC2007
• Managing Metabolica Abnormalities in the Psychiatrically Ill. A Clinical Guide for Psychiatrists. 
  Chapter: Severe mental illness and obesity. 
  Page 55 - 120McElroy SL, Guerdjikova A, Kotwal R, Keck PE, Jr.Editors: Bermudes RA, Keck PE, Jr, McElroy SL.American Psychiatric Publishing, Inc., Washington, DC2007
• Bipolar Pyschopharmacotherapy: Caring for the Patient 
  Chapter: A comparison of "second generation antipsychotics" in the treatment of bipolar disorder: focus on clozapine, quetiapine, ziprasidone, and aripiprazole. 
  Page 125 - 134Keck PE, Jr, McElroy SLEditors: Akiskal HS, Tohen M.John Wiley & Sons, London, UK2006
• Obesity and Mental Disorders 
  Chapter: Medical management of obesity associated with mood disorders. 
  Page 369 - 416McElroy SL, Kotwal R, Keck PE, Jr.Editors: McElroy SL, Allison DB, Bray GA.Marcel Dekker, New York2006
• Obesity and Mental Disorders 
  Chapter: Psychotropic-induced weight gain: liability, mechanisms and treatment approaches. 
  Page 307 - 354McIntyre RS, Konarski JZ, Keck PE, Jr.Editors: McElroy SL, Allison DB, Bray GA.Marcel Dekker, New York2006
• Obesity and Mental Disorders 
  Chapter: Obesity and mood disorders. 
  Page 41 - 92McElroy SL, Kotwal R, Malhotra S, Nelson EB, Keck PE, Jr, Nemeroff CBEditors: McElroy SL, Allison DB, Bray GA.Marcel Dekker, New York2006
• Essentials of Clinical Psychopharmacology 
  Chapter: Treatment of bipolar disorder. 
  Page 479 - 502Keck PE, Jr, McElroy SLEditors: Schatzberg AF, Nemeroff CB.American Psychiatric Press, Inc., Washington, DCEdition 2nd,2006
• The American Psychiatric Publishing Textbook of Mood Disorders 
  Chapter: Lithium and mood stabilizers. 
  Page 281 - 290Keck PE, Jr, McElroy SLEditors: Stein DJ, Kupfer DJ, Schatzberg AF.American Psychiatric Press, Washington, DC2005
• Bipolar Disorder: Treatment and Management 
  Suppes T, Keck PE, Jr.Compact Clinicals Medical Publishers, Kansas City, MO2004
• Join now to see all

Abstracts/Posters

• Efficacy and safety of low- and high-dose cariprazine in patients with acute mania associated with bipolar I disorder.
  Calabrese JR, Keck PE, Jr, Lu K, Laszlovszky I, Sartace A, Nemeth G, Durgam S, Abstracts of the Annual Meeting of the American Psychiatric Association, San Francisco, CA, 1/20/2013
• Cariprazine effects on YMRS items: results of a pooled analysis of 3 randomized, double-blind, placebo-controlled trials in bipolar mania.
  Keck PE, Jr, Zukin S, Lu K, Laszlovszky I, Nemeth G, Durgam S, Abstracts of the Annual Meeting of the American Psychiatric Association, San Francisco, CA, 1/20/2013
• Borderline personality features in rapid cycling bipolar disorder in relationship to episode frequency.
  Kupka RW, Post RM, Altshuler LL, Frye MA, Grunze H, Keck PE, Jr, Leverich GS, McElroy SL, Suppes T, Nolen WA, Abstracts of the 6th International Conference on Bipolar Disorders, Pittsburgh, PA, 1/15/2009
• Delay to first treatment is inversely related to age of onset of bipolar disorder and an independent contributor to a poor outcome in adulthood.
  Post RM, Leverich GS, Kupka RW, Keck PE, McElroy SL, Altshuler LL, Frye MA, Luckenbaugh D, Rowe M, Grunze H, Suppes T, Nolen WA, Abstracts of the 6th International Conference on Bipolar Disorders, Pittsburgh, PA, 1/15/2009
• Mixed depression in bipolar disorder: prevalence rate and clinical correlates during naturalistic follow up.
  Suppes T, Helleman G, Frye MA, McElroy SL, Nolen W, Kupka R, Leverich G, Grunze H, Altshuler LL, Keck PE, Post RM, Abstracts of the 6th International Conference on Bipolar Disorders, Pittsburgh, PA, 1/15/2009
• Prevalence of mixed depression and its impact on remission: a controlled evaluation.
  Frye MA, Helleman G, Suppes T, McElroy SL, Grunze H, Altshuler LL, Keck PE, Kupka R, Nolen W, Leverich G, Post RM, Abstracts of the 6th International Conference on Bipolar Disorders, Pittsburgh, PA, 1/15/2009
• Early antipsychotic effects on glucose metabolism during treatment of new-onset psychosis and mania.
  Keck P, D'Allesio D, Strakowski S, Abstracts of the Annual Meeting of the American College of Neuropsychopharmacology, 1/12/2009
• What is a mood stabilizer?
  Keck PE, Jr., World Psychiatry, Abstracts of the World Psychiatric Association Meeting, Florence, Italy, 1/3/2009
• Analysis of potential drug-drug interaction pairs associated with antipsychotics among Medicaid patients with schizophrenia, schizoaffective disorder, or bipolar disor...
  Guo JJ, Patel N, Kelton C, Keck PE, Jr., Abstracts of the ISPOR 3rd Asia Pacific Conference, Seoul, South Korea, 1/8/2008
• Economic and clinical consequences associated with potential drug-drug interactions between antipsychotics and concomitant medications in patients with schizophrenia.
  Guo JJ, Patel N, Kelton C, Keck PE, Jr., Abstracts of the ISPOR 3rd Asia Pacific Conference, Seoul, South Korea, 1/8/2008
• The standards for bipolar excellence (STABLE) project: a bipolar disorder quality improvement initiative to develop and validate evidence-based performance measures fo...
  Golden WE, Keck PE, Jr, Williams JW, Harshaw Q, Shillington A, Brewster C, Abstracts of the ISPOR 13th Annual International Meeting, Toronto, Canada, 1/5/2008
• Consequences associated with potential drug-drug interactions between antipsychotics and concomitant medications in patients with schizophrenia.
  Guo JJ, Keck PE, Jr., Abstracts of the ISPOR 13th Annual International Meeting, Toronto, Canada, 1/5/2008
• Analysis of potential drug-drug interaction pairs associated with antipsychotics among Medicaid patients with schizophrenia or bipolar disorder.
  Yonghua J, Guo JJ, Keck PE, Jr., Abstracts of the Annual Meeting of the American Psychiatric Association, Washington, DC, 1/4/2008
• Placebo-controlled study of divalproex extended release loading monotherapy in bipolar outpatients with moderate-to-severe hypomania or mild mania.
  McElroy SL, Keck PE, Jr., Abstracts of the Annual Meeting of the American Psychiatric Association, Washington, DC, 1/4/2008
• Description of suicidal behaviors in bipolar anxiety.
  Rogers JE, Sheehan DV, McElroy SL, Suppes T, Keck PE, Jr, Janavis J, Harnett-Sheehan K, New Research Abstracts of the 160th Annual Meeting of the American Psychiatric Association, San Diego, CA, 1/21/2007
• Aripiprazole monotherapy in the treatment of acute bipolar mania: a randomized, placebo- and lithium-controlled study.
  Keck PE, Jr, Torbeyns A, Marcus RN, McQuade RD, Forbes A, New Research Abstracts of the 160th Annual Meeting of the American Psychiatric Association, San Diego, CA, 1/21/2007
• The efficacy of risperidone in bipolar anxiety.
  Sheehan DV, McElroy SL, Suppes T, Sheehan KH, Keck PE, Jr, Janavis J, Raj A, New Research Abstracts of the 160th Annual Meeting of the American Psychiatric Association, San Diego, CA, 1/21/2007
• Suggestive linkage of 5p15.2 loci to ADHD features measured by Wender Questionnaire in bipolar disorder.
  Joo E-J, Greenwood T, Schork N, McKinney R, Sadovnick AD, Remick RA, McElroy SL, Keck PE, Jr, Kelsoe JR, Biol Psychiatry, Abstracts of the 62nd Annual Meeting of the Society of Biological Psychiatry, San Diego, CA, 1/19/2007
• Dopamine and serotonin receptor binding and antipsychotic efficacy.
  Richtand NR, Welge J, Logue A, Keck PE, Strakowski SM, McNamara R, Biol Psychiatry, Abstracts of the 62nd Annual Meeting of the Society of Biological Psychiatry, San Diego, CA, 1/19/2007
• Mood stabilizer and subsequent need for adjunctive antidepressant: naturalistic follow up of SFBN.
  Abulseoud OA, Hellemann G, Frye MA, Altshuler LL, Keck PE, Jr, McElroy SL, Suppes T, Nolen WA, Kupka RA, Grunze H, Leverich GS, Post RM, Bipolar Disorders, Seventh International Conference on Bipolar Disorder, Pittsburgh, PA, 1/7/2007
• Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, placebo- and lithium-controlled study.
  Keck PE, Jr, Sanchez R, Torbeyns AF, Marcus RN, McQuade RD, Forbes A, Bipolar Disorders, Seventh International Conference on Bipolar Disorder, Pittsburgh, PA, 1/7/2007
• Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network.
  Kelly DI, Suppes T, Keck PE, Jr, McElroy SL, Altshuler LL, Frye MA, Nolen WA, Kupka RW, Grunze H, Leverich GS, Mintz J, Luckenbaugh DA, Fischer EG, Post RM, Bipolar Disorders, Seventh International Conference on Bipolar Disorder, Pittsburgh, PA, 1/7/2007
• Maintenance therapy of aripiprazole vs. placebo in bipolar I disorder: a double-blind, placebo-controlled, 74-week extension of a 26-week study.
  McIntyre RS, Keck PE, Calabrese JR, Momah C, Carson W, McQuade R, Marcus R, Carlson BX, Eudicone J, Sanchez R, Bipolar Disorders, Seventh International Conference on Bipolar Disorder, Pittsburgh, PA, 1/7/2007
• Aripiprazole for relapse prevention in bipolar disorder: a 26-week placebo controlled study.
  Keck PE, Jr, Sanchez R, Marcus RN, Carson WH, Jr, Rollin L, Iwamoto T, Stock EG, American Psychiatric Association Annual Meeting, Toronto, Canada, 1/20/2006
• Ziprasidone's long-term efficacy and safety in bipolar disorder.
  Keck PE, Jr, Potkin SG, Giller D, Ice K, Warrington L, Dunn J, American Psychiatric Association Annual Meeting, Toronto, Canada, 1/20/2006
• Join now to see all

Lectures

• 2016 Addiction: Why is There a Heroin Epidemic? 
  Quebec City, Canada - 1/6/2016
• Evidence-based Treatment of Acute Mania. 
  Columbus, OH - 1/19/2015
• The Global Burden of Mental Illness 
  Key Largo, FL - 1/13/2015
• Depression and Bipolar Disorder: #1 US Public Health Problem. 
  Mason, OH - 1/3/2015
• "Clinical-Pathological Correlates of Bipolar and Eating Disorders." 
  Santiago, Chile - 1/1/2015
• Bipolar and Borderline Personality Disorders. 
  Dallas, TX - 1/24/2014
• The Bipolar Patient: Unraveling the Web of Complexity. 
  Los Angeles, CA - 1/23/2014
• Making Sense of Suicide. 
  1/22/2014
• "Treatment of Bipolar Disorder and Co-morbid Conditions." 
  Cleveland, OH - 1/1/2014
• The Bipolar Patient-Unraveling the Web of Complexity 
  Palm Beach, FL - 1/24/2013
• Second Generation Antipsychotics in Bipolar Disorder: State of the Evidence. 
  Curitiba, Brazil - 1/24/2013
• Treatment Algorithm for Bipolar Disorder: Acute Mania. 
  Naples, FL - 1/20/2013
• Recovery, Remission, Wellness-The Realizable Goals of Diagnosis and Treatment 
  Crystal Lake, IL - 1/20/2013
• Bipolar Disorder and the Challenge of Co-occurring Conditions. 
  Phoenix, AZ - 1/10/2013
• "Bipolar Depression." 
  Cincinnati, OH - 1/1/2013
• Pharmacotherapy of Bipolar Disorder. 
  Sendai, Japan - 1/16/2012
• Role of Dopamine and Dopaminergic Medicines in Bipolar Disorder. 
  Osaka, Japan - 1/15/2012
• Treatment-Resistant Depression, in Managing Depression in Special Populations 
  Cincinnati, OH - 1/30/2011
• Principles of Treating Individuals with Complex Co-morbidity. 
  Indianapolis, IN - 1/23/2011
• Neuromodulation in the Treatment of Depression. 
  Covington, KY - 1/21/2011
• Bipolar Disorder and The Challenge of Comorbidity 
  Columbus, OH - 1/17/2011
• Bipolar Disorder and Co-Occurring Illness. 
  Malibu, CA - 1/9/2011
• Bipolar Disorder 
  Evanston, IL - 1/5/2011
• Changing Attitudes, Changing Lives 
  Cincinnati, OH - 1/10/2010
• Bipolar Disorder-The Most Complex and Comorbid Disorder. 
  Cincinnati, OH - 1/5/2010
• Join now to see all

Other

• Limited treatment is an issue. 
  Keck PE Jr., Cincinnati Enquirer, Op-Ed
  1/23/2012
• Stigma should be removed from mental illness. 
  Keck PE Jr., Cincinnati Enquirer, Guest Column
  1/23/2011
• Bipolar disorder: An update on recent therapeutic trials. 
  Keck PE, Jr, McElroy SL, Hawkins JM, Psychopharmacology Review
  1/1/2011
• Coping in a troubled economy. 
  Keck PE Jr, Arthur R, Cincinnati Gentleman
  1/1/2009
• US ready for massive shift in treatment of mental health. 
  Keck PE Jr., Cincinnati Business Courier
  1/8/2008
• The brain as a substrate for psychotropic therapeutics. 
  Keck PE, Jr, Strakowski SM, Renshaw PF, CNS Spectrums
  1/1/2007
• The anticonvulsant zonisamide in bipolar illness: clinical response and weight loss. 
  Leverich GS, McElroy SL, Altshuler LL, Frye MA, Grunze H, Keck PE, Jr, Kupka R, Nolen WA, Suppes T, Walden J, Post RM, Aspects of Affect
  1/1/2005
• An overview of recent findings of the Stanley Foundation Bipolar Network (SFBN) (Part II): Focus on anticonvulsants. 
  Post RM, Altshuler LL, Frye MA, Suppes T, Keck PE, Jr, McElroy SL, Leverich GS, Nolen WA, Kupka R, Walden J, Grunze H, Aspects of Affect
  1/1/2005
• Reassessing carbamazepine in the treatment of bipolar disorder: clinical implications of the new data. 
  Akiskal HS, Fuller MA, Hirschfeld RM, Keck PE, Ketter TA, Weisler RH, CNS Spectrums
  1/1/2005
• Treatment of bipolar disorder: a guide for patients and families. 
  Kahn D, Keck PE, Jr, Perlis RH, Otto MW, Ross R, A Postgraduate Medicine Special Report (McGraw-Hill), pp.109-116
  Minneapolis, MN - 1/1/2004
• Managing Impulsivity in Psychiatry. 
  Keck PE, Jr, Hollander E, Johnson BA, McElroy SL, Strakowski SM, Health Learning Systems Monograph Series
  Wayne, NJ - 1/1/2004
• The Expert Consensus Guidelines Series. Treatment of Bipolar Disorder 2004. 
  Keck PE, Jr, Perlis RH, Otto MW, Carpenter D, Docherty JP, Ross R, A Postgraduate Medicine Special Report (McGraw-Hill), pp.1-108
  Minneapolis, MN - 1/1/2004
• Mania and atypical antipsychotics. Clinical Interview. 
  Keck PE, Jr., Johns Hopkins University School of Medicine Advanced Studies in Medicine
  1/1/2004
• Olanzapine alone or in combination for acute mania. 
  Rendell JM, Gijsman HJ, Keck PE, Goodwin GM, Geddes JR, Cochrane Database Systems Review
  1/1/2003
• New antiepileptic agents for the treatment of bipolar disorder. 
  Delbello MP, Kowatch RA, Keck PE, Jr., Child and Adolescent Psychopharmacology Newsletter
  1/1/2002
• What Makes a Drug a Mood-Stabilizer? 
  Paul E. Keck, Jr., MD, PsychLink telecast, Interactive Medical Networks
  Dallas, TX - 1/1/2001
• Realities of Reintegration: Multidimensional Approaches to Optimize Outcomes in Psychosis and Mood Disorder. 
  Paul E. Keck, Jr., MD, Provision Medical Education Telecast
  New York, NY - 1/1/2000
• The efficacy of atypical antipsychotics against negative symptoms in schizophrenia and mood disturbances in affective disorders. 
  Keck PE, Jr.
  1/1/2000
• Depression in women. 
  Arnold LM, Keck PE, Jr., Columbia Womens Health Monograph
  1/1/2000
• Treatment of Psychotic Disorders for the New Century: From Social Containment to Reintegration 
  Paul E. Keck, Jr., MD, CENTERNET National Videoconference
  New York, NY - 1/1/1999
• Economic implications of pharmacotherapy for bipolar disorder: An update. 
  Keck PE, Jr, McElroy SL, Arnold LM, Economics of Neuroscience
  1/1/1999
• Gabapentin treatment of adults and adolescents with bipolar disorder: a literature review. 
  Soutullo CA, McElroy SL, Keck PE, Jr., Psychiatric Networks
  1/1/1999
• Pharmacoeconomics of lithium and divalproex sodium in the treatment of bipolar disorder. 
  Goldberg JF, Altshuler LL, Frye M, Keck PE, Jr., Directions in Psychiatry
  1/1/1998
• Mood stabilizers do not always control depression, mania. 
  Keck PE, Jr., Psychopharmacology Update
  1/1/1998
• Practical pharmacology. A pharmacoeconomic model of divalproex vs. lithium in the acute and prophylactic treatment of bipolar disorder. 
  Keck PE, Jr., Medscape Mental Health
  1/1/1997
• Join now to see all